Scope
Reference
PHA-FTS-60744
Description
Supply of Aflibercept, Golimumab, Dapagliflozin
Total value (estimated)
- £45,077,163 excluding VAT
- £54,092,565 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 January 2026 to 31 December 2027
- Possible extension to 31 December 2028
- 3 years
Description of possible extension:
12 month extension option available
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKL - Wales
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Enquiry deadline
14 November 2025, 10:00am
Tender submission deadline
17 November 2025, 10:00am
Submission address and any special instructions
Tenders may be submitted electronically
Yes
Languages that may be used for submission
English
Award decision date (estimated)
1 December 2025
Recurring procurement
Publication date of next tender notice (estimated): 1 March 2027
Award criteria
| Name | Description | Type | Order of importance |
|---|---|---|---|
| Product Quality/Acceptability | Pass/Fail |
Quality | 1 |
| Financial (overall cost of contract) | Weighting: 85 |
Cost | 2 |
| Enviromental/Social Value/Community Benefits | Weighting: 15 |
Quality | 3 |
Other information
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Open procedure
Contracting authority
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- NHS Organisation Data Service: RQF
Imperial Park Unit 5, Celtic Way
Newport
NP10 8BE
United Kingdom
Email: jennifer.tresilian@wales.nhs.uk
Website: http://nwssp.nhs.wales/ourservices/procurement-services/
Region: UKL21 - Monmouthshire and Newport
Organisation type: Public authority - central government
Devolved regulations that apply: Wales